Ercros (CHIX:ECRE) Other Current Liabilities: €124.9 Mil (As of Mar. 2026)


CHIX:ECRE Ercros SA CHIX:ECRE
68 GF Score
Price €3.40
GF Value €2.94
! 7 Warning Signs
View Full Analysis

What is Ercros Other Current Liabilities?

Ercros CHIX:ECRE 68 Other Current Liabilities is €124.9 Mil as of Mar. 2026. GuruFocus rates CHIX:ECRE with a GF Score™ of 68/100 and a GF Value™ of €2.94. The stock has 7 warning signs investors should review.

Ercros's other current liabilities for the quarter that ended in Mar. 2026 was €124.9 Mil.

Ercros's quarterly other current liabilities increased from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€25.5 Mil) and increased from Dec. 2025 (€25.5 Mil) to Mar. 2026 (€124.9 Mil).

Ercros's annual other current liabilities declined from Dec. 2023 (€36.2 Mil) to Dec. 2024 (€33.1 Mil) and declined from Dec. 2024 (€33.1 Mil) to Dec. 2025 (€25.5 Mil).


Ercros Other Current Liabilities Related Terms


Ercros Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ercros's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ercros Other Current Liabilities Chart

Ercros Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.40 39.03 36.16 33.07 25.52

Ercros Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.82 22.18 0.00 25.52 124.95
CHIX:ECRE
68GF Score
Ercros SA CHIX:ECRE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ercros Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €124.9 Mil mean?
Ercros (CHIX:ECRE) has a Other Current Liabilities of €124.9 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ercros.
Is Ercros' Other Current Liabilities too high?
Ercros' current Other Current Liabilities is €124.9 Mil. Overall, Ercros has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Ercros' Other Current Liabilities compare to DOW?
Ercros' Other Current Liabilities of €124.9 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Chemicals company?
A good Other Current Liabilities depends on the Chemicals industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ercros. Ercros's current Other Current Liabilities is €124.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ercros stock overvalued right now?
Ercros (CHIX:ECRE) has a current Other Current Liabilities of €124.9 Mil. The stock's GF Value™ is €2.94, compared to a current price of €3.40 — trading 15.5% above its estimated fair value. The current Other Current Liabilities is €124.9 Mil. Ercros' overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ercros (CHIX:ECRE), the current Other Current Liabilities is €124.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ercros (CHIX:ECRE) Overvalued in 2026?

Based on GuruFocus' analysis, Ercros stock appears to be overvalued. The current stock price of €3.40 is trading 15.5% above its estimated GF Value™ of €2.94.

Key valuation signals for CHIX:ECRE:

  • Other Current Liabilities: €124.9 Mil
  • GF Value™: €2.94 vs. price of €3.40 (15.5% above fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the CHIX:ECRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ercros Business Description

Address Avinguda Diagonal, 593-595, Barcelona, ESP, 08014
Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.
68GF Score

Get the complete analysis for CHIX:ECRE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price
€2.94
GF Value